megestrol acetate has been researched along with Carcinoma, Ductal, Breast in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carli, AF; Correale, P; Francini, E; Francini, G; Guarnieri, A; Licchetta, A; Magliocca, A; Migali, C; Pascucci, A; Piccolomini, A; Remondo, C; Savelli, V | 1 |
Karakuzu, A; Koc, M; Ozdemir, S | 1 |
Carnero López, B; Carrasco Alvarez, JA; Fernández Pérez, I; Gentil González, M; González Villarroel, P; Páramo, C; Vázquez Tuñas, ML | 1 |
Andersen, J; Cold, S; Ejlertsen, B; Ewertz, M; Jacobsen, EH; Jensen, D; Kamby, C; Møller, KA; Møller, S; Philip, P | 1 |
Altaras, M; Beyth, Y; Cohen, I; Cordoba, M; Shulman, A; Tepper, R | 1 |
2 trial(s) available for megestrol acetate and Carcinoma, Ductal, Breast
Article | Year |
---|---|
Oral metronomic chemo-hormonal-therapy of metastatic breast cancer with cyclophosphamide and megestrol acetate.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Female; Humans; Liver Neoplasms; Lung Neoplasms; Megestrol Acetate; Middle Aged; Neoplasm Staging; Survival Rate; Treatment Outcome | 2010 |
Tamoxifen for one year versus two years versus 6 months of Tamoxifen and 6 months of megestrol acetate: a randomized comparison in postmenopausal patients with high-risk breast cancer (DBCG 89C).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Mastectomy, Segmental; Megestrol Acetate; Middle Aged; Postmenopause; Risk Factors; Survival Rate; Tamoxifen; Treatment Outcome | 2008 |
3 other study(ies) available for megestrol acetate and Carcinoma, Ductal, Breast
Article | Year |
---|---|
Multiple cutaneous metastases from male breast carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Doxorubicin; Epirubicin; Fatal Outcome; Fluorouracil; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Mastectomy, Radical; Megestrol Acetate; Middle Aged; Paclitaxel; Palliative Care; Skin Neoplasms | 2006 |
Megestrol acetate-induced adrenal insufficiency.
Topics: Adrenal Insufficiency; Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Megestrol Acetate; Pericardial Effusion | 2008 |
Estrogen and progesterone receptor expression of decidual endometrium in a postmenopausal woman treated with tamoxifen and megestrol acetate.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Endometrium; Estrogens; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Postmenopause; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1994 |